CJC-1295 (No DAC) / Ipamorelin is a multi-component peptide research blend combining a stabilized growth-hormone-releasing-hormone fragment analog commonly referred to as CJC-1295 No DAC or Mod GRF(1-29) with ipamorelin, a short synthetic growth-hormone-secretagogue receptor ligand.
The two components are scientifically distinct: the CJC-1295 No DAC component is used in GHRH-receptor research, while ipamorelin is used in GHSR-focused assay systems. In a combined research material, analytical work should confirm the identity, relative composition, stability, and chromatographic behavior of both peptides rather than treating the blend as a single molecular entity.
Scientific / Analytical Profile
- Type: two-component peptide blend
- Component 1: stabilized GHRH(1-29)-type peptide analog
- Component 2: ipamorelin, a synthetic GHSR research ligand
- Analytical priority: component-specific identity, relative composition, purity, co-elution risk, and blend stability
- Research positioning: non-clinical receptor, analytical, and method-development work only
Batch-specific identity, purity, and analytical results should be confirmed against the applicable Certificate of Analysis and lot documentation.
Research Use Only. This material is intended solely for controlled laboratory, analytical, and scientific research. It is not for human or veterinary use or administration, diagnosis, treatment, prevention, cosmetic use, food use, or personal use.
